Angiography Devices Market Overview
The global angiography devices market was valued at $8,780.5 million in 2021, and is projected to reach $15,931.1million by 2031, registering a CAGR of 6.0% from 2022 to 2031.
The rise in number of cardiovascular diseases such as heart attack, stroke, and coronary block artery, increase in advanced products, devices and technologies in the market and their extensive usage in the treatment of cardiovascular diseases drive the growth of market.
Angiography is the process used for medical imaging of blood vessel of the neck, brain, heart, heart and kidneys. It is performed using contrast agents that are injected into blood stream through a thin plastic tube (catheter) placed directly in the blood vessel, called angiograms. It is used to detect abnormalities or blockages in blood vessels throughout the circulatory system, and in some organs to diagnose heart diseases, kidney functions, detect kidney cysts or tumors, aneurysm, blood clot, arteriovenous in the brain, and diagnose problems with the retina of the eye.
Key Market Dynamics
The key factors driving the angiography devices market growth include:
Increase in geriatric population prone to chronic heart disease.
Rising prevalence of cardiovascular diseases (CVDs) such as coronary artery blockage, heart attack, atherosclerosis, ischemic stroke, aneurysm, brain blood clots, hypertension, myocardial infarction, and arrhythmia.
Growing cases of blockages in blood vessels of the heart, brain, kidney, and liver.
Increasing demand for minimally invasive procedures for accurate disease diagnosis.
Furthermore:
The National Center for Health Statistics reports that more than 795,000 people in the U.S. suffer a stroke each year.
The Centers for Disease Control and Prevention (CDC) states that approximately 87% of all reported strokes are ischemic.
These factors collectively boost demand for angiography devices worldwide.
Segment Review
By Product
The angiography systems segment held the largest market share in 2021.
This dominance is attributed to the increasing use of angiography systems in diagnosing chronic heart diseases and the rising prevalence of blocked blood vessels in both the heart and brain.
By Application
The diagnostic segment accounted for the highest market share in 2021.
Growth is driven by the rising prevalence of heart diseases such as coronary artery blockage, angina, arrhythmia, myocardial infarction, and heart attack.
Increasing cases of heart attacks globally further fuel segment growth during the forecast period.
By Technology
The X-ray angiography segment was the highest revenue contributor in 2021.
Factors driving this dominance include the high adoption of X-ray angiography for diagnosing arterial narrowing in the brain and vascular blockages, as well as growing awareness regarding its clinical benefits in treatment planning.
By Region
North America dominated the angiography devices market in 2021, supported by:
Rising prevalence of chronic heart disease.
Presence of key market players.
Advancements in healthcare technology.
Strong healthcare infrastructure and higher healthcare expenditure.
Competitive Landscape
Some of the major companies that operate in the global Angiography devices market are Abbott Laboratories, Angiodynamics, Inc., Boston Scientific Corporation, B. Braun Melsungen AG, General Electric Company, Koninklijke Philips N.V., Medtronic Inc., Merit Medical Systems, Inc., Siemens Healthcare Gmbh, and Shimadzu Corporation.
Looking for Customization? https://www.alliedmarketresearch.com/request-for-customization/2854
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the angiography devices market analysis from 2021 to 2031 to identify the prevailing angiography devices market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the angiography devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global angiography devices market trends, key players, market segments, application areas, and market growth strategies.
Read More:
Operating Room Management Market Worth USD 10.0 billion by 2031 at a CAGR of 13.0%
Global Narcolepsy Drugs Market Set for Strong Growth Through 2030
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
